 | • レポートコード：QY20ST-01613 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のキネトーシス薬市場について種類別（抗コリン作用薬、抗ヒスタミン薬、その他）、用途別（成人、子供）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・キネトーシス薬市場の概要 ・世界の主要地域別キネトーシス薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のキネトーシス薬市場規模2015-2026：種類別（抗コリン作用薬、抗ヒスタミン薬、その他） ・世界のキネトーシス薬市場規模2015-2026：用途別（成人、子供） ・キネトーシス薬の北米市場規模2015-2020 ・キネトーシス薬のヨーロッパ市場規模2015-2020 ・キネトーシス薬の中国市場規模2015-2020 ・キネトーシス薬の日本市場規模2015-2020 ・キネトーシス薬の東南アジア市場規模2015-2020 ・キネトーシス薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・キネトーシス薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・キネトーシス薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Kinetosis Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Kinetosis Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Kinetosis is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Kinetosis Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Kinetosis Drugs industry.
Based on our recent survey, we have several different scenarios about the Kinetosis Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Kinetosis Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Kinetosis Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Kinetosis Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Kinetosis Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Kinetosis Drugs market. The report also includes nautical information, where it shows Kinetosis Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Kinetosis Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Kinetosis Drugs market.
Geographical Analysis:
Based on region, the global Kinetosis Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Kinetosis Drugs market are
GlaxoSmithKline
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Mylan
Sandoz
Pfizer
Myungmoon Pharm
Caleb Pharmaceuticals
Segment by Type
Anticholinergic
Antihistamines
Others
Segment by Application
Adults
Children
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Kinetosis Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Kinetosis Drugs market.
• The market share of the global Kinetosis Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Kinetosis Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Kinetosis Drugs market.
1 Kinetosis Drugs Market Overview
1.1 Kinetosis Drugs Product Scope
1.2 Kinetosis Drugs Segment by Type
1.2.1 Global Kinetosis Drugs Sales by Type (2020-2026)
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Kinetosis Drugs Segment by Application
1.3.1 Global Kinetosis Drugs Sales Comparison by Application (2020-2026)
1.3.2 Adults
1.3.3 Children
1.4 Kinetosis Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Kinetosis Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Kinetosis Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Kinetosis Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Kinetosis Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Kinetosis Drugs Industry
1.5.1.1 Kinetosis Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Kinetosis Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Kinetosis Drugs Players to Combat Covid-19 Impact
2 Kinetosis Drugs Estimate and Forecast by Region
2.1 Global Kinetosis Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Kinetosis Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Kinetosis Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Kinetosis Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Kinetosis Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Kinetosis Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Kinetosis Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Kinetosis Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Kinetosis Drugs Estimates and Projections (2015-2026)
2.4.3 China Kinetosis Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Kinetosis Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Kinetosis Drugs Estimates and Projections (2015-2026)
2.4.6 India Kinetosis Drugs Estimates and Projections (2015-2026)
3 Global Kinetosis Drugs Competition Landscape by Players
3.1 Global Top Kinetosis Drugs Players by Sales (2015-2020)
3.2 Global Top Kinetosis Drugs Players by Revenue (2015-2020)
3.3 Global Kinetosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kinetosis Drugs as of 2019)
3.4 Global Kinetosis Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Kinetosis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Kinetosis Drugs Players (Opinion Leaders)
4 Global Kinetosis Drugs Market Size by Type
4.1 Global Kinetosis Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Kinetosis Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Kinetosis Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Kinetosis Drugs Price by Type (2014-2020)
4.2 Global Kinetosis Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Kinetosis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Kinetosis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Kinetosis Drugs Price Forecast by Type (2021-2026)
5 Global Kinetosis Drugs Market Size by Application
5.1 Global Kinetosis Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Kinetosis Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Kinetosis Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Kinetosis Drugs Price by Application (2015-2020)
5.2 Global Kinetosis Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Kinetosis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Kinetosis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Kinetosis Drugs Price Forecast by Application (2021-2026)
3 North America Kinetosis Drugs Market Facts & Figures
3.2 North America Kinetosis Drugs Sales Market Share by Company (2015-2020)
3.3 North America Kinetosis Drugs Sales Market Share by Type (2015-2020)
3.4 North America Kinetosis Drugs Sales Market Share by Application (2015-2020)
4 Europe Kinetosis Drugs Market Facts & Figures
4.2 Europe Kinetosis Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Kinetosis Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Kinetosis Drugs Sales Market Share by Application (2015-2020)
5 China Kinetosis Drugs Market Facts & Figures
5.2 China Kinetosis Drugs Sales Market Share by Company (2015-2020)
5.3 China Kinetosis Drugs Sales Market Share by Type (2015-2020)
5.4 China Kinetosis Drugs Sales Market Share by Application (2015-2020)
6 Japan Kinetosis Drugs Market Facts & Figures
6.2 Japan Kinetosis Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Kinetosis Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Kinetosis Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Kinetosis Drugs Market Facts & Figures
7.2 Southeast Asia Kinetosis Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Kinetosis Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Kinetosis Drugs Sales Market Share by Application (2015-2020)
8 India Kinetosis Drugs Market Facts & Figures
8.2 India Kinetosis Drugs Sales Market Share by Company (2015-2020)
8.3 India Kinetosis Drugs Sales Market Share by Type (2015-2020)
8.4 India Kinetosis Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Kinetosis Drugs Business
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Kinetosis Drugs Corporation Information
12.1.2 GlaxoSmithKline Kinetosis Drugs Business Overview and Total Revenue
12.1.3 GlaxoSmithKline Kinetosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Kinetosis Drugs Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Prestige Brands
12.2.1 Prestige Brands Kinetosis Drugs Corporation Information
12.2.2 Prestige Brands Kinetosis Drugs Business Overview and Total Revenue
12.2.3 Prestige Brands Kinetosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Prestige Brands Kinetosis Drugs Products Offered
12.2.5 Prestige Brands Recent Development
12.3 WellSpring Pharmaceutical Corporation
12.3.1 WellSpring Pharmaceutical Corporation Kinetosis Drugs Corporation Information
12.3.2 WellSpring Pharmaceutical Corporation Kinetosis Drugs Business Overview and Total Revenue
12.3.3 WellSpring Pharmaceutical Corporation Kinetosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 WellSpring Pharmaceutical Corporation Kinetosis Drugs Products Offered
12.3.5 WellSpring Pharmaceutical Corporation Recent Development
12.4 Baxter International
12.4.1 Baxter International Kinetosis Drugs Corporation Information
12.4.2 Baxter International Kinetosis Drugs Business Overview and Total Revenue
12.4.3 Baxter International Kinetosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Baxter International Kinetosis Drugs Products Offered
12.4.5 Baxter International Recent Development
12.5 Mylan
12.5.1 Mylan Kinetosis Drugs Corporation Information
12.5.2 Mylan Kinetosis Drugs Business Overview and Total Revenue
12.5.3 Mylan Kinetosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Kinetosis Drugs Products Offered
12.5.5 Mylan Recent Development
12.6 Sandoz
12.6.1 Sandoz Kinetosis Drugs Corporation Information
12.6.2 Sandoz Kinetosis Drugs Business Overview and Total Revenue
12.6.3 Sandoz Kinetosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sandoz Kinetosis Drugs Products Offered
12.6.5 Sandoz Recent Development
12.7 Pfizer
12.7.1 Pfizer Kinetosis Drugs Corporation Information
12.7.2 Pfizer Kinetosis Drugs Business Overview and Total Revenue
12.7.3 Pfizer Kinetosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pfizer Kinetosis Drugs Products Offered
12.7.5 Pfizer Recent Development
12.8 Myungmoon Pharm
12.8.1 Myungmoon Pharm Kinetosis Drugs Corporation Information
12.8.2 Myungmoon Pharm Kinetosis Drugs Business Overview and Total Revenue
12.8.3 Myungmoon Pharm Kinetosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Myungmoon Pharm Kinetosis Drugs Products Offered
12.8.5 Myungmoon Pharm Recent Development
12.9 Caleb Pharmaceuticals
12.9.1 Caleb Pharmaceuticals Kinetosis Drugs Corporation Information
12.9.2 Caleb Pharmaceuticals Kinetosis Drugs Business Overview and Total Revenue
12.9.3 Caleb Pharmaceuticals Kinetosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Caleb Pharmaceuticals Kinetosis Drugs Products Offered
12.9.5 Caleb Pharmaceuticals Recent Development
13 Kinetosis Drugs Manufacturing Cost Analysis
13.1 Kinetosis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Kinetosis Drugs
13.4 Kinetosis Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Kinetosis Drugs Distributors List
14.3 Kinetosis Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Kinetosis Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Kinetosis Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Kinetosis Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Kinetosis Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Kinetosis Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Kinetosis Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Kinetosis Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Kinetosis Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Kinetosis Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Kinetosis Drugs Revenue Share by Region (2015-2020)
Table 13. Global Kinetosis Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Kinetosis Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Kinetosis Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Kinetosis Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Kinetosis Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Kinetosis Drugs Sales Share by Company (2015-2020)
Table 19. Global Kinetosis Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Kinetosis Drugs Revenue Share by Company (2015-2020)
Table 21. Global Kinetosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kinetosis Drugs as of 2019)
Table 22. Global Kinetosis Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Kinetosis Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Kinetosis Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Kinetosis Drugs Players
Table 27. Global Kinetosis Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Kinetosis Drugs Sales Share by Type (2015-2020)
Table 29. Global Kinetosis Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Kinetosis Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Kinetosis Drugs Sales Share by Type (2021-2026)
Table 32. Global Kinetosis Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Kinetosis Drugs Revenue Share by Type (2021-2026)
Table 34. Global Kinetosis Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Kinetosis Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Kinetosis Drugs Sales Share by Application (2015-2020)
Table 37. Global Kinetosis Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Kinetosis Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Kinetosis Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Kinetosis Drugs Sales Share by Application (2021-2026)
Table 41. Global Kinetosis Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Kinetosis Drugs Revenue Share by Application (2021-2026)
Table 43. Global Kinetosis Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Kinetosis Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Kinetosis Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Kinetosis Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Kinetosis Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Kinetosis Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Kinetosis Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Kinetosis Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Kinetosis Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Kinetosis Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Kinetosis Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Kinetosis Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Kinetosis Drugs Sales Market Share by Type (2015-2020)
Table 56. China Kinetosis Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Kinetosis Drugs Sales Market Share by Company (2015-2020)
Table 58. China Kinetosis Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Kinetosis Drugs Sales Market Share by Type (2015-2020)
Table 60. China Kinetosis Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Kinetosis Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Kinetosis Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Kinetosis Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Kinetosis Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Kinetosis Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Kinetosis Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Kinetosis Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Kinetosis Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Kinetosis Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Kinetosis Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Kinetosis Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Kinetosis Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Kinetosis Drugs Sales Market Share by Application (2015-2020)
Table 74. India Kinetosis Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Kinetosis Drugs Sales Market Share by Company (2015-2020)
Table 76. India Kinetosis Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Kinetosis Drugs Sales Market Share by Type (2015-2020)
Table 78. India Kinetosis Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Kinetosis Drugs Sales Market Share by Application (2015-2020)
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Kinetosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Kinetosis Drugs Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Prestige Brands Corporation Information
Table 86. Prestige Brands Description and Business Overview
Table 87. Prestige Brands Kinetosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Prestige Brands Kinetosis Drugs Product
Table 89. Prestige Brands Recent Development
Table 90. WellSpring Pharmaceutical Corporation Corporation Information
Table 91. WellSpring Pharmaceutical Corporation Description and Business Overview
Table 92. WellSpring Pharmaceutical Corporation Kinetosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. WellSpring Pharmaceutical Corporation Kinetosis Drugs Product
Table 94. WellSpring Pharmaceutical Corporation Recent Development
Table 95. Baxter International Corporation Information
Table 96. Baxter International Description and Business Overview
Table 97. Baxter International Kinetosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Baxter International Kinetosis Drugs Product
Table 99. Baxter International Recent Development
Table 100. Mylan Corporation Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Kinetosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Mylan Kinetosis Drugs Product
Table 104. Mylan Recent Development
Table 105. Sandoz Corporation Information
Table 106. Sandoz Description and Business Overview
Table 107. Sandoz Kinetosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sandoz Kinetosis Drugs Product
Table 109. Sandoz Recent Development
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Kinetosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Pfizer Kinetosis Drugs Product
Table 114. Pfizer Recent Development
Table 115. Myungmoon Pharm Corporation Information
Table 116. Myungmoon Pharm Kinetosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Myungmoon Pharm Description and Business Overview
Table 118. Myungmoon Pharm Kinetosis Drugs Product
Table 119. Myungmoon Pharm Recent Development
Table . Caleb Pharmaceuticals Corporation Information
Table . Caleb Pharmaceuticals Kinetosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Caleb Pharmaceuticals Description and Business Overview
Table . Caleb Pharmaceuticals Kinetosis Drugs Product
Table . Caleb Pharmaceuticals Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Kinetosis Drugs Distributors List
Table 128. Kinetosis Drugs Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Kinetosis Drugs Product Picture
Figure 2. Global Kinetosis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Kinetosis Drugs Market Share by Application in 2020 & 2026
Figure 6. Adults Examples
Figure 7. Children Examples
Figure 8. Global Kinetosis Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Kinetosis Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Kinetosis Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Kinetosis Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Kinetosis Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Kinetosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Kinetosis Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Kinetosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Kinetosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Kinetosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Kinetosis Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Kinetosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Kinetosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Kinetosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Kinetosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Kinetosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Kinetosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Kinetosis Drugs Players Market Share by Revenue in Kinetosis Drugs 2015 & 2019
Figure 26. Kinetosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Kinetosis Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Kinetosis Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Kinetosis Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Kinetosis Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Kinetosis Drugs Sales Market Share by Type in 2019
Figure 32. United States Kinetosis Drugs Sales Market Share by Type in 2019
Figure 33. Europe Kinetosis Drugs Sales Market Share by Company in 2019
Figure 34. Europe Kinetosis Drugs Sales Market Share by Type in 2019
Figure 35. Europe Kinetosis Drugs Sales Market Share by Application in 2019
Figure 36. China Kinetosis Drugs Sales Market Share by Company in 2019
Figure 37. China Kinetosis Drugs Sales Market Share by Type in 2019
Figure 38. China Kinetosis Drugs Sales Market Share by Application in 2019
Figure 39. Japan Kinetosis Drugs Sales Market Share by Company in 2019
Figure 40. Japan Kinetosis Drugs Sales Market Share by Type in 2019
Figure 41. Japan Kinetosis Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Kinetosis Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Kinetosis Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Kinetosis Drugs Sales Market Share by Application in 2019
Figure 45. India Kinetosis Drugs Sales Market Share by Company in 2019
Figure 46. India Kinetosis Drugs Sales Market Share by Type in 2019
Figure 47. India Kinetosis Drugs Sales Market Share by Application in 2019
Figure 48. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Prestige Brands Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. WellSpring Pharmaceutical Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Myungmoon Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Caleb Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Kinetosis Drugs
Figure 59. Manufacturing Process Analysis of Kinetosis Drugs
Figure 60. Kinetosis Drugs Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
抗コリン性乗り物酔い薬の世界市場レポート2020 A recently published report by QY Research titled Global Anticholinergic Travel Sickness Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statisticall…- 抗ヒスタミン剤乗り物酔い薬の世界市場レポート2020 A recently published report by QY Research titled Global Antihistamines Travel Sickness Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically…
- 抗ヒスタミン剤乗り物酔い薬の世界市場レポート2020 A recently published report by QY Research titled Global Antihistamines Travel Sickness Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically…
- 旅行酔い薬の世界市場レポート2020 A recently published report by QY Research titled Global Travel Sickness Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accur…
- 酔い止め薬の世界市場レポート2020 A recently published report by QY Research titled Global Motion Sickness Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accur…